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The majority of encephalitis induced by herpes simplex virus type I (HSV-1) is due to viral reactivation
from latency, but few studies have investigated the factors inﬂuencing viral reactivation in the brain
due to the lack of a sensitive assay. We have established an ex vivo explant assay, which induced
efﬁcient viral reactivation in the dissociated mouse brain. Applying this assay, we investigated the
infection of four HSV-1 strains with varying degrees of neurovirulence in three mouse strains with
different levels of susceptibility to HSV-1 infection. We found that virulent HSV-1 strains and
susceptible mouse strains exhibited prolonged viral growth during acute infection, increased latent
viral genomes, and efﬁcient explant reactivation in the brain stem. Collectively, both viral neuroviru-
lence and host susceptibility positively correlate with HSV-1 reactivation from the explanted
mouse brain.
& 2012 Elsevier Inc. All rights reserved.Introduction
Herpes simplex virus type I (HSV-1) infects about 80–90% of
the human population in the world (Casrouge et al., 2006; Corey
et al., 1988; Roizman et al., 2007; Smith and Robinson, 2002;
Standberry et al., 1997). This neurotropic virus replicates in
peripheral tissues before spreading to replicate in peripheral
sensory ganglia and the central nervous system (CNS). Subse-
quently, virus establishes latency by maintaining its genomes in
the neurons of both ganglia and CNS (Roizman et al., 2007).
During latency, latency-associated transcripts are abundantly
expressed, whereas the expression of other viral genes is severely
repressed. Latent virus can reactivate periodically to induce
lesions mostly in the periphery. In few cases, latent virus can
reactivate in the brain to cause encephalitis.
In humans, encephalitis is the most devastating consequence of
HSV infections (Stroop, 1986). HSV encephalitis is also the most
common cause of sporadic, fatal encephalitis, with an incidence of
1 in 200,000 individuals per year (Roizman et al., 2007). It is
associated with 70% mortality in untreated patients and 30%
mortality in treated patients (Roizman et al., 2007; Whitley, 1991).ll rights reserved.
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sequelae, and only 2.5% of all patients return to normal neurological
function (Roizman et al., 2007). In addition, HSV infection of
the brain has been suspected to be involved in a number of tragic
neurological disorders, such as epilepsy, Alzheimer’s disease,
Parkinson’s disease, and multiple sclerosis (Beffert et al., 1998;
Gannicliffe et al., 1985; Hemling et al., 2003; Itzhaki et al., 1997;
Martin, 1981). Both primary and recurrent infections can
induce encephalitis (Steiner, 2011). HSV-1 genomes can be
detected in the human brain (Fraser et al., 1981; Jamieson et al.,
1991), and 70% of encephalitis cases occur as a recurrent infection
(Nahmias et al., 1982).
The murine model has been used extensively for studying HSV
reactivation, as HSV establishes latency and then reactivates upon
stimulation in a manner similar to human infection. Viral gen-
omes are present in the brain and ganglia of latently infected mice
(Cabrera et al., 1980; Deatly et al., 1988; Drummond et al., 1994;
Rock and Fraser, 1983). However, virus rarely reactivates from the
minced brain explant when assayed ex vivo by a conventional
method, which efﬁciently reactivates virus from the minced
ganglion explant (Cabrera et al., 1980). The failure of HSV to
reactivate from the CNS has led to the assumption that ganglia are
the prime source of reactivated virus. Lately, we have developed a
sensitive and consistent ex vivo assay by dissociating the explanted
mouse brain tissue into single cells, which enhances cell viability to
promote efﬁcient viral reactivation, especially from the brain stem
with a frequency of up to 88% (Chen et al., 2006). One advantage of
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the trigeminal ganglion and the CNS is severed, reactivation can be
determined in the brain stem independently from that occurring in
the trigeminal ganglion. The brainstem explant used for our study is
free of trigeminal ganglion neurons, as our previous study detected
HSV-1 reactivation in all 16 minced trigeminal ganglion explants,
but not in any of 16 minced brainstem explants (Chen et al., 2006).
In the present study, we utilized the ex vivo assay to investigate the
correlation between neurovirulence, host susceptibility, and viral
reactivation in the dissociated brainstem explant. Four HSV-1 strains
demonstrating varying neurovirulence properties were examined in
the context of three mouse strains with differing levels of suscept-
ibility to HSV-1 infection. Our results showed that the neuroviru-
lence of HSV-1 strains and the susceptibility of host positively
correlate with viral reactivation from the explanted brain.Table 1
LD50 values of four HSV-1 strains in three mouse strains.
HSV-1 strain Mouse strain
KOS 42.0107 42.0107 42.0107
RE 2.3104 3.6106 42.0107
294.1 5.1103 1.5104 1.2107
McKrae o2.0103 2.3103 1.3104
Results are expressed as PFU/mouse.Results
The virulence of HSV-1 strains and the susceptibility of mouse strains
used for study
To test whether and how the virulence of HSV-1 strains and
the susceptibility of hosts to HSV-1 infection would affect viral
reactivation in the explanted brain, we employed four HSV-1
strains (KOS, RE, 294.1, and McKrae) and three commonly used
mouse strains (ICR, BALB/c, and C57BL/6). We ﬁrst characterized
the virulence of four HSV-1 strains by determining their 50%
lethal doses (LD50s). Six- to eight-week-old male mice were
anesthetized, infected with virus on the right eye following
corneal scariﬁcation, and monitored for their survival. KOS at a
dose of 2107 PFU (the maximum dose feasible for cornealFig. 1. Infection of three mouse strains with four HSV-1 strains. The death rates of ICR
doses of HSV-1 strains, KOS, RE, 294.1, or McKrae are shown.inoculation in our study) failed to induce death in all three strains
of mice, however, the other three virus strains did induce death in
mice. Several doses of these viruses, encompassing death rates
from approximately 0% to 100% were used to infect mice for
determining the LD50 (Fig. 1 and Table 1). ICR mice were highly
susceptible to McKrae with 100% and more than 90% death rates
after infection with 2104 and 2103 PFU of virus, respectively,
so we recorded o2103 PFU as the LD50 (Table 1). The LD50s of
McKrae, 294.1, RE, and KOS were 2.3103, 1.5104, 3.6106,
and 42.0107 PFU in BALB/c mice, respectively. Thus, McKrae is
the most virulent strain, followed by 294.1, RE, and KOS. This
same virulence ranking was also observed in ICR and C57BL/6
mice, although the LD50s obtained from different mouse strains
were not the same. For further comparisons with other viral
activities, such as viral growth and reactivation, we designated
the values of Log10 (1/LD50) as virulence scores for four virus
strains because of the inverse relationship between LD50 and viral
virulence. BALB/c, ICR and C57BL/6 mice yielded deﬁned LD50s for
three, two, and two virus strains, respectively, so the values
obtained from BALB/c mice were used to designate the scores., BALB/c,and C57BL/6 mice (n¼12–16 per data point) infected with the indicated
H.-W. Yao et al. / Virology 433 (2012) 116–123118KOS failed to induce death in BALB/c mice, so we assigned
2.0107 PFU (the maximum dose feasible for corneal inoculation
in our study) as the LD50 for KOS. Accordingly, the virulence
scores of KOS, RE, 294.1, and McKrae were 7.3, 6.6, 4.2, and
3.4, respectively.
The results in Table 1 also showed that the three mouse strains
differed in their susceptibilities to HSV-1 infection. The LD50s of
294.1 in ICR, BALB/c and C57BL/6 mice were 5.1103, 1.5104,
and 1.2107 PFU, respectively. Thus, ICR is the most susceptible
mouse strain compared with the moderately susceptible strain,
BALB/c, and the relatively resistant strain, C57BL/6. A similar
trend in the mouse susceptibility was also observed when virus
strains RE and McKrae were used for inoculation. Virus strains,
294.1, RE, McKrae, and KOS yielded deﬁned LD50s in three, two,
two, and zero mouse strains, respectively, so we chose the values
obtained from 294.1 to designate the susceptibility scores [Log10
(1/LD50)] for ICR, BALB/c, and C57BL/6 mice, which were 3.7,
4.2, and 7.1, respectively.
Virulent HSV-1 strains exhibit high levels of acute replication, latency
establishment, and explant reactivation frequencies in the mouse
brain stem
We next studied the inﬂuence of HSV-1 virulence on viral
acute replication, latency establishment, and explant reactivation
in the brain stem of C57BL/6 mice. The brain stem was chosen for
investigation, because our previous mouse report showed that
this brain region had the highest levels of HSV-1 acute replication,
latent genomes, and reactivation in the CNS when compared with
the spinal cord and other brain regions (cerebellum, olfactory
bulbs, frontal cortex, and hippocampus) (Chen et al., 2006).
Additionally, recurrent brainstem encephalitis has been reported
in humans, although the case number is less than the encephalitis
localized in temporal and frontal lobes (Gorospe et al., 2004;
Roman-Campos and Toro, 1980; Tyler et al., 1995). C57BL/6 mice
were used for experiments because their resistance to HSV-1
infection, especially to highly virulent virus strains, such as
McKrae and 294.1, allowed mice to survive for further analysis
during latency. Following inoculation of C57BL/6 mice with
1105 PFU of virus, few PFU were detected in the brain stem
from day 1 to 3 post-infection (p.i.), which was consistent with a
previous study performed in the mouse brain (Knotts et al., 1974).
The titers of four virus strains reached peaks at day 5 p.i. without
signiﬁcant differences between each other (Fig. 2A). The titers of
KOS and RE, which had low virulence scores, dropped to almost
undetectable levels at day 7 p.i. The titers of 294.1 and McKrae,
which had high virulence scores, were comparable and much
greater than those of KOS and RE by about 3 and 2 logs at 7 and 8
days p.i. respectively. Accordingly, more virulent virus strains
maintained prolonged acute replication in the mouse brain stem.
For further comparisons, we calculated the areas under the
growth curves for the four virus strains and set the growth curve
area of KOS as 100%. Therefore, the relative growth of RE, 294.1,
and McKrae were 100%, 300%, and 299%, respectively (Fig. 2B).
Some mortality was observed from days 7 to 14 p.i. The ﬁnal
survival rates of mice infected with KOS, RE, 294.1, or McKrae
were 100%, 100%, 83%, and 24% (18 out of 74), respectively. Mice
succumbing to death displayed signs of encephalitis manifested
by rufﬂed fur, hunched posture, and ataxia. Most importantly, the
death rates of infected mice were correlated with viral growth in
the brain stem. These observations suggest that the mice died
of encephalitis, and that the four virus strains varied in their
neurovirulence.
At day 30 p.i., we harvested brain stems from mice infected with
KOS, RE, 294.1, or McKrae (n¼6 for each group) to detect infectious
virus by plaque assay on Vero cell monolayers, but failed to detectany infectious virus in samples, showing that the viruses established
latency in the mouse brain stem. To determine the levels of latency
established by the four virus strains, we harvested mouse brain
stems to quantify viral genomes using quantitative real-time PCR.
The numbers of KOS, RE, 294.1, and McKrae genomes detected in
mice were 4.0, 4.6, 5.4, and 5.5 log copies/brain stem, respectively
(Fig. 2C). In mouse brain stems, the genome number of KOS was
signiﬁcantly less than those of the other three virus strains (Po0.05,
Mann–Whitney U test), and the genome number of RE was
signiﬁcantly less than those of 294.1 and McKrae (Po0.01, Mann–
Whitney U test). The difference in 294.1 and McKrae genome
numbers was not statistically signiﬁcant.
Latency-associated transcripts are abundantly expressed and
serve as a hallmark for latent infection. We quantiﬁed these
transcripts using quantitative real-time RT-PCR, as few reports
have measured the transcripts in the latently infected mouse
brain. The numbers of transcripts detected in mice infected with
KOS, RE, 294.1, or McKrae for 30 days were 6.8, 7.4, 8.4, and
8.2 log copies/brain stem, respectively (Fig. 2D). In mouse brain
stems, KOS and RE transcript numbers were signiﬁcantly less than
294.1 and McKrae transcript numbers (Po0.05, Mann–Whitney U
test), but the differences between KOS and RE transcript numbers
as well as between 294.1 and McKrae transcript numbers were
not statistically signiﬁcant. Results of viral genomes and latency-
associated transcripts show that the latency levels established by
four HSV-1 strains in the mouse brain vary.
To assess for the reactivation of latent virus, we harvested
mouse brain stems at day 30 p.i. and performed an ex vivo explant
assay using the dissociation method as previously described
(Chen et al., 2006). The reactivation frequencies of KOS, RE,
294.1, and McKrae were 0, 10, 60, and 80%, respectively
(Fig. 2E). The reactivation frequency of KOS was signiﬁcantly less
than those of 294.1 and McKrae (Po0.05, Fisher’s exact test), and
the reactivation frequency of RE was signiﬁcantly less than that of
McKrae (Po0.01). The differences in reactivation frequencies
between KOS and RE as well as between 294.1 and McKrae were
not statistically signiﬁcant.
We analyzed and found very strong correlations between the
virulence scores and relative growth, latent genomes, or explant
reactivation frequencies of the four virus strains in the mouse
brain stem (r240.91, Po0.05, Pearson’s correlation test; Fig. 3A–C).
Thus, virulent HSV-1 strains replicate efﬁciently during acute infec-
tion to subsequently establish high levels of latency and reactivate
efﬁciently in the mouse brain during explant. The correlation
between the reactivation frequencies and latent genomes of the
four virus strains was also very strong (r2¼0.92, Pearson’s correla-
tion test; Fig. 3D), suggesting that HSV-1 reactivation frequencies
positively correlate with latent viral loads.
Susceptible mouse strains display high levels of HSV-1 acute
replication, latent genomes, and explant reactivation frequencies in
the brain stem
We next investigated the inﬂuence of mouse susceptibility to
HSV-1 infection on viral acute replication, latent genomes, and
explant reactivation in the brain stem. KOS was used for studies,
so that susceptible mice, like ICR, would survive for further
analysis during latency. Following inoculation of mice with
1105 PFU of KOS, in brain stems, the average viral titer of ICR
mice was signiﬁcantly greater than those of C57BL/6 and BALB/c
mice (Po0.05, Mann–Whitney U test), whereas the average viral
titers of C57BL/6 and BALB/c mice were not much different at day
5 p.i. (Fig. 4A). The viral titer of C57BL/6 mice, which had a low
susceptibility score, dropped to an almost undetectable level,
whereas the viral titers of BALB/c and ICR mice, those with high
susceptibility scores, were still elevated and signiﬁcantly greater
Fig. 2. The infection of the brain stem of C57BL/6 mice by four HSV-1 strains. The titers (A), relative growth (B), numbers of latent genomes (C) and latency-associated
transcripts (D), and reactivation frequencies (E) of HSV-1 strains, KOS, RE, 294.1, and McKrae, in the brain stem of C57BL/6 mice at the indicated times after infection are
shown. In panel A, data shown are means7SEM (error bars) of ﬁve samples per data point. **Po0.01 by the Mann–Whitney U test between 294.1 or McKrae and KOS or
RE groups. In panel B, the growth curves area of KOS is set as 100% and the growth curve areas of other three virus strains are calculated accordingly. In panels C and D,
each point on scattergrams represents an individual sample, and horizontal lines represent the mean values of each group. *Po0.05; **Po0.01 and ***Po0.001 by the
Mann–Whitney U test. In panel E, the number above bars are the number of samples positive out of the number tested. yPo0.05 and yyPo0.01 by the Fisher exact test.
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7 p.i. These results revealed that HSV-1 replication in the brain
stem of susceptible mouse strains was prolonged and sometimes
increased when compared with more resistant mouse strains. For
further comparisons, we calculated the areas under the growth
curves for the three mouse strains and set the viral growth curve
area of C57BL/6 mice as 100%. Accordingly, the relative growth of
BALB/c and ICR mice were 244%, and 356%, respectively (Fig. 4B).
At day 30 p.i., all infected C57BL/6, BALB/c, and ICR mice
survived. Again, infectious virus was not detected in brain stems
of infected C57BL/6, BALB/c, and ICR mice (n¼6 for each group),
showing that KOS established latency in the tissue. The numbers of
viral genomes detected in C57BL/6, BALB/c, and ICR mice were 4.0,
4.9, and 5.9 log copies/brain stem, respectively (Fig. 4C), which weresigniﬁcantly different from each other (Po0.01, Mann–Whitney U
test). Mouse brain stems were also harvested and assayed for the
reactivation of latent virus. The reactivation frequencies of C57BL/6,
BALB/c, and ICR mice were 0, 31, and 33%, respectively, which were
not signiﬁcantly different from each other (Fig. 4D).
Correlations were found between the susceptibility scores of
the three mouse strains and the relative growth, latent genomes, or
reactivation frequencies of KOS in these strains (r240.81, Pear-
son’s Correlation test; Fig. 5A–C). Thus, HSV-1 replicates efﬁciently
in susceptible mouse strains during acute infection, leading to
increased viral genomes and reactivation frequencies in the
latently infected brain. Again, a correlation was found between
the reactivation frequencies and latent genomes of KOS in the
three mouse strains (r2¼77, Pearson’s Correlation test; Fig. 5D).
Fig. 3. Correlations between the virulence and activities of four HSV-1 strains in the brain stem of C57BL/6 mice. The virulence scores were plotted against the relative
growth (A), mean numbers of latent genomes (B), or reactivation frequencies (C) of KOS, RE, 294.1, and McKrae. (D) The reactivation frequencies of four HSV-1 strains were
plotted against the mean numbers of latent genomes. The best-ﬁt lines and their correlation coefﬁcients (r2) are displayed in each panel.
H.-W. Yao et al. / Virology 433 (2012) 116–123120Discussion
Our results provide the ﬁrst evidence that both viral neuro-
virulence and host susceptibility positively correlate with HSV-1
reactivation in the explanted mouse brain. Unlike in the
explanted mouse trigeminal ganglion, both virus and host genet-
ics fail to inﬂuence viral reactivation, as reactivated virus was
recovered in all trigeminal ganglia from C57BL/6 mice latently
infected with 1105 PFU of KOS, RE, 294.1, or McKrae and from
BALB/c and ICR mice latently infected with 1105 PFU of KOS
(n¼6–10 in each group) after cultivating explants for more than
48 h. Virulent HSV-1 has been shown to reactivate early in mouse
trigeminal ganglion explants, as the reactivation frequencies of
virulent and avirulent HSV-1 strains were different at 22 h, but
not at 48 h, after cultivating (Sawtell and Thompson, 2004). In the
future, studies are needed to investigate HSV-1 reactivation in the
mouse brain in vivo, as in vivo studies performed on the mouse
trigeminal ganglion demonstrated positive correlation between
viral replication and reactivation frequency (Sawtell, 1998;
Sawtell et al., 2001). In vivo studies can address not only the
inﬂuence of viral neurovirulence and host susceptibility on viral
reactivation in the brain, but also the importance of recurrent
brain infection in the development of encephalitis.
Our study raises an old, but unanswered issue regarding what
accounts for the variation in neurovirulence between HSV-1
strains. Previous reports using mutant viruses with certain viral
genes deleted found that several viral genes contribute to viral
neurovirulence by increasing the peak level of acute viral replica-
tion in the mouse brain (Bolovan et al., 1994; Strand and Leib,
2004). These reports cannot explain our results, because fourHSV-1 strains reach comparable peak titers in the brain stems of
C57BL/6 mice. These four HSV-1 strains also replicate equally well
in vitro in Vero cells (Supplemental Fig. 1). However, the ability to
sustain replication in the brain stem is vastly different between the
virulent and avirulent strains. Further studies using intertypic
recombinants of KOS and McKrae to map the gene responsible for
sustained acute replication in the mouse brain may address what
accounts for the variation in neurovirulence between HSV-1 strains.
In our study, three mouse strains with different degrees of
susceptibility to HSV-1-induced encephalitis were used to inves-
tigate the inﬂuence of host susceptibility on viral reactivation
from the latently infected mouse brain. Among the mouse strains
tested, C57BL/6 mice are the most resistant strain when com-
pared with BALB/c, a ﬁnding consistent with previous reports
(Kastrukoff et al., 2010; Kirchner et al., 1978; Lopez, 1975;
Lundberg et al., 2008). In addition to encephalitis, C57BL/6 mice
are also resistant to HSV-induced stromal keratitis (Norose et al.,
2002) and retinitis (Pepose and Whittum-Hudson, 1987). For
decades, studies mapping the genetic basis responsible for the
natural resistance of C57BL/6 mice to HSV infection have not
provided conclusive answers (Halford et al., 2004). Our results
showed early clearance of HSV-1 in the brain stem of C57BL/6
mice when compared with BALB/c and ICR mice. Future investi-
gations on how HSV-1 replication in the brain stem of C57BL/6
mice is suppressed may address what accounts for the variation
in mouse susceptibility to HSV-1-induced encephalitis.
Our results in Table 1 also highlight the issue that appropriate
hosts, like BALB/c mice with moderate susceptibility to HSV-
induced diseases, are needed to clearly distinguish HSV strains
with varying degrees of virulence. Similarly, suitable HSV strains,
Fig. 4. The infection of brain stem of three mouse strains by HSV-1 strain KOS. The titers (A), relative growth (B), numbers of latent genomes (C), and reactivation
frequencies (D) of KOS in the brain stems of ICR, BALB/c, and C57BL/6 mice at the indicated times after infection are shown. In panel A, data shown are means7SEM
(error bars) of ﬁve samples per data point. *Po0.05 by the Mann–Whitney U test between ICR and BALB/c or C57BL/6 mouse groups. **Po0.01 by the Mann–Whitney U
test between ICR or BALB/c and C57BL/6 mouse groups, respectively. In panel B, the growth curve area of ICR mice is set as 100% and the growth curve areas of BALB/c and
C57BL/6 mice are calculated accordingly, In panel C, each point on the scattergram represents an individual sample, and horizontal lines represent the mean values for each
group. **Po0.01 and ***Po0.001 by the Mann–Whitney U test. In panel D, the numbers above bars are the number of samples positive out of the number tested.
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susceptibility to virus-induced diseases. Most importantly, the
present study supplies the necessary information regarding the
proper HSV-1 strains or mouse strains for future studies of HSV
reactivation in the dissociated mouse brain explant.
In humans, 70% of encephalitis cases occur as a recurrent
infection (Nahmias et al., 1982). However, in the past, the failure
to detect viral reactivation from the minced mouse brain explant
assessed by an ex vivo assay led to the assumption that the brain
lacks authenticity as a latently infected tissue (Minson, 1983).
Consequently, the detection of virus in the brain of latently
infected mice subjected to immunosuppression was interpreted
as the spread of reactivated virus from the trigeminal ganglia
(Kastrukoff et al., 1981; Sekizawa and Openshaw, 1984). Our
previous (Chen et al., 2006) and present ex vivo studies showing
efﬁcient viral reactivation from the explanted mouse brain with a
frequency up to 80–88% strongly suggest that the latent HSV in
the brain can reactivate. Importantly, the present mouse study
demonstrates that both virus and host genetics can impact on
latent DNA loads and reactivation frequencies in the dissociated
brainstem explant. These results indicate that previous reports
using the presence or absence of viral genomes in brain speci-
mens from neurological disease-affected patients as the only
index for addressing the involvement of HSV in neurological
diseases might be inadequate, thus explaining contradictory
results (Beffert et al., 1998; Itzhaki et al., 1997). More parameters,
such as the viral genome level or the presence of infectious virusin patient brain specimens, should be evaluated to further
delineate the involvement of HSV in human neurological dis-
orders, as our mouse results demonstrate a positive correlation
between levels of viral latent genomes and ex vivo reactivation
frequency in the brain stem.
Materials and methods
Cells, viruses, and mice
Vero cells were maintained and propagated according to
American Type Culture Collection instructions. Wild-type HSV-1
strains KOS, RE, 294.1 (Sacks et al., 1989), and McKrae were
propagated and titrated on Vero cell monolayers. C57BL/6, BALB/c,
and ICR mice were obtained from The Jackson Laboratory (Bar
Harbor, ME) and maintained in the laboratory animal center of our
college. All mouse experiment protocols were approved by the
Laboratory Animal Committee of National Cheng Kung University.
Assay of viral virulence and mouse susceptibility
Six- to eight-week-old male ICR, BALB/c, and C57BL/6 mice
were anesthetized and infected with virus on the right eye
following scarifying the cornea with 20 strokes of a needle.
Several viral doses were tested. For each dose, at least six
mice were inoculated. The deaths of mice were monitored for
15 days. Experiments were performed at least twice. The LD50 for
Fig. 5. Correlations between the susceptibility of three mouse strains and KOS activities in brain stems. The relative growth (A), mean numbers of latent genomes
(B), or reactivation frequencies (C) of KOS in the brain stems were plotted against the susceptibility scores of three mouse strains. (D) The reactivation frequencies of KOS in
the brain stems of three mouse strains were plotted against the mean numbers of latent genomes. The best-ﬁt lines and their correlation coefﬁcients (r2) are displayed in
each panel.
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Muench, 1938).
Measurement of viral titers in the mouse brain stem
Mouse brain stems were harvested and weighed. Each brain
stem was placed in a tube with 1 ml of Dulbecco’s Modiﬁed Eagle
medium containing 5% newborn calf serum and frozen at 80 1C.
Frozen samples were thawed, homogenized with glass grinders,
and frozen again. The resulting samples were thawed, sonicated,
and centrifuged. The supernatants were titrated for infectious
virus by plaque assay on Vero cell monolayers.
Quantitative real-time PCR and RT-PCR
Mouse brain stems were harvested at day 30 p.i., frozen, and
homogenized in solution containing guanidine thiocyanate. One
tenth homogenate was used to extract DNA, and the rest of
homogenate was used to extract total RNA. The amounts of viral
(thymidine kinase) and cellular (adipsin) DNA in samples were
quantiﬁed by real-time PCR using SYBR Green PCR Master Mix
and an ABI Prism 7900 Sequence Detection System (Applied
Biosystems, Foster City, CA) according to manufacturer’s protocols
as previously described (Chen et al., 2006) with modiﬁcations in
PCR conditions (95 1C for 10 s, 60 1C for 1 min, and 82 1C for 12 s
for 40 cycles with data collected at 60 1C). Quantiﬁcation stan-
dards composed of RE genomes and adipsin were used to
determine the amounts of viral genomes and cellular DNA in
samples, and then the amount of viral genomes was normalized
to the amount of cellular DNA. The amounts of latency-associatedtranscripts and b-actin mRNA in samples were quantiﬁed by real-
time RT-PCR using primers and the quantiﬁcation standard of
latency-associated transcripts as previously described (Kramer
and Coen, 1995) with modiﬁcations using PCR conditions
described above to collect data at 82 1C. The amount of latency-
associated transcripts was normalized to the amount of b-actin in
the sample.
Ex vivo explant assay of HSV-1 reactivation from latently infected
mouse neural tissues using the dissociation method
Male or female mice were infected with virus as described
above. Thirty days after infection, mice were sacriﬁced, and brain
stems and right trigeminal ganglia were harvested to assay for the
reactivation of latent virus using the dissociation method as
previously described (Chen et al., 2006).
Statistical analyses
For statistical comparison, levels of viral loads, latent genomes,
and latency-associated transcripts were analyzed by the Mann–
Whitney U test. Viral reactivation frequencies were analyzed by
the Fisher’s exact test. The correlation coefﬁcients were analyzed
by the Pearson’s Correlation test.Acknowledgments
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